Seagen
Company Information
As of 6/2/21
Country
U.S.
Headquarters
Bothell, Wash.
Industry
Pharmaceuticals
CEO
Clay B. Siegall
Website
Company Type
Public
Ticker
SGEN
Revenues ($M)
$2,175.5
Profits ($M)
$613.7
Market Value ($M)
$25,176.1
Employees
2,092
Changed name from Seattle Genetics, Oct. 9, 2020. Market value as of March 31, 2021.
Key Financials (Last Fiscal Year)
$ millions
% change
Revenues ($M)
$2,175.5
137.3%
Profits ($M)
$613.7
-
Assets ($M)
$4,000.9
-
Total Stockholder Equity ($M)
$3,488.1
-
Profit Ratios
Profit as % of Revenues
28.2%
Profits as % of Assets
15.3%
Profits as % of Stockholder Equity
17.6%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)
337
EPS % Change (from 2019)
-
EPS % Change (5 year annual rate)
-
EPS % Change (10 year annual rate)
-
Total Return
Total Return to Investors (2020)
53.3%
Total Return to Investors (5 year, annualized)
31.3%
Total Return to Investors (10 year, annualized)
27.9%
Measure Up Diversity & Inclusion Metrics
Measure Up Rank
-
Provides Day Care Services
-
Facilitates Employee Resource Groups
-
Has a Policy on Board Diversity
-
Has a Policy on Diversity and Opportunity
-
Has Targets Toward Diversity and Opportunity
-
% of Employees With Disabilities
-
% of New Employees Who Are Women
-
% of Employees Who Are Women
-
% of Managers Who Are Women
-
Gender Pay Gap %
-
% of Board Members Who Are Minorities
-
% of Employees Who Are Minorities
-
% of Managers Who Are Minorities
-
Minorities Salary Gap %
-
Lists ranking Seagen